Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 401 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
Patents for C07D 401 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom (107,979)
12/2005
12/14/2005CN1708492A Selected CGRP antagonists, method for production and use thereof as medicament
12/14/2005CN1708483A Process for making pyrazole compounds
12/14/2005CN1708482A N-sulfonyl-4-methyleneamino-3-hydroxy-2-pyridones as antimicrobials
12/14/2005CN1708481A N-alkyl-4-methyleneamino-3-hydroxy-2-pyridones as antimicrobials
12/14/2005CN1708306A Quinazolinone compounds as calcilytics
12/14/2005CN1708303A Derivatives of pyridinalkyl-amonoalkyl-1h-indole inhibiting receptors 5-HT and recapture of serotonin which can be used as antidepressant and anxiolitic
12/14/2005CN1706840A Methylsulfonate of pyrimidine derivative and its prepn process, application and medicine composition
12/14/2005CN1706824A Compound as CCR5 agonist
12/14/2005CN1231479C Naphthostyrils compounds
12/14/2005CN1231478C Acid-addition salt of hexahydropyridine compound having optical activity, and its prepn. process
12/14/2005CN1231477C Potassium salt of (I(S))-omeprazole
12/14/2005CN1231476C Substd. pyridine herbicides
12/14/2005CN1231473C Substituted arylpyrazines
12/14/2005CN1231471C 4-amino-5-cyano-2-anilino-pyrimidine derivatives and their use as inhbitors of cell-cycle kinases
12/14/2005CN1231467C High affinity ligands for nociceptin receptor ORL-1
12/14/2005CN1231466C New piperidine derivatives
12/14/2005CN1231465C Biphenylsulfonyl cyanamides, method for the production thereof and their utilization as a medicament
12/14/2005CN1231464C Novel 3-substituted urea derivatives and medicinal use thereof
12/14/2005CN1231440C Novel tricyclic compound
12/14/2005CN1231215C (Imidazol-5-yl) methyl-2-quinolinone derivatives as inhibitors of smooth muscle cell proliferation
12/13/2005US6974876 Method for preparing intermediates useful in synthesis of retroviral protease inhibitors
12/13/2005US6974828 3-((2-((3-((Amino(imino)methyl)amino)benzoyl)amino)phenyl)sulf anyl)- 3-(3-pyridinyl)propanoic acid, for example; angiogenic inhibitors; antitumor, -carcinogenic, -metastatic, -diabetic, -arthritic and inflammatory agents; bone disorders
12/13/2005US6974827 For use as pesticides and herbicides
12/13/2005US6974826 such as 3-(3,5,5,8,8-pentamethyl-5,6,7,8-tetrahydro-2-naphthyl)-4-methoxybenzylidene-2,4-thiazolidinedione; Hodgkin's disease
12/13/2005US6974824 N-substituted-4-(m-hydroxyphenyl)piperidine derivated and esters thereof, used to bind a kappa opioid receptor; treating drug addiction
12/13/2005US6974822 Treating osteoarthritis or rheumatoid arthritis
12/13/2005US6974817 CCR1 receptor antagonists; inhibitors of MIP-1 alpha (CCL3) binding to its receptor CCR1 found on inflammatory and immunomodulatory cells; macrophage inflammatory protein (MIP)
12/13/2005US6974813 For therapy of perioperative myocardial ischemic injury in mammals, including humans
12/13/2005US6974812 such as 2-chloro-N-(1-hydroxy-cycloheptylmethyl)-5-[4-(2-hydroxy-3-methoxy-propyl)-3,5-dioxo-4,5-dihydro-3H-[1,2,4]triazin-2-yl]-benzamide; purinergic receptors (P2x7 E); for treatment of interleukin-1 associated disorders (rheumatoid arthritis)
12/13/2005US6974810 4,5-Dihydro-1H-pyrazole derivatives having potent CB1-antagonistic activity
12/13/2005US6974485 Oxidative hair dyes containing plant extracts
12/13/2005CA2234066C Substituted imidazoles having anti-cancer and cytokine inhibitory activity
12/11/2005WO2005113544A1 Substantially pure 2-{[2-(2-methylamino-pyrimidin-4-yl)-1h-indole-5-carbonyl]-amino}-3-(phenylpyridin-2-yl-amino)-propionic acid as an ikb kinase inhibitor
12/11/2005CA2566213A1 Substantially pure 2-{[2-(2-methylamino-pyrimidin-4-yl)-1h-indole-5-carbonyl]-amino}-3-(phenylpyridin-2-yl-amino)-propionic acid as an ikb kinase inhibitor
12/08/2005WO2005117242A1 Method and installation means for installing an electrical machine
12/08/2005WO2005116029A1 Cyclohexylalanine derivatives as dipeptidyl peptidase-iv inhibitors for the treatment or prevention of diabetes
12/08/2005WO2005116027A2 Indazole and indolone derivatives and their use as pharmaceuticals
12/08/2005WO2005116018A1 TYROSINE DERIVATIVES SUBSTITUTED BYALKANOYLAS hPPARα & hPPARϜ ANGONISTS
12/08/2005WO2005116014A1 Proline derivatives and their use as dipeptidyl peptidase iv inhibitors
12/08/2005WO2005116012A1 Pyrrolidine derivative
12/08/2005WO2005116011A1 A novel stereoselective synthesis of benzimidazole sulfoxides
12/08/2005WO2005116010A1 Ep4 receptor agonist, compositions and methods thereof
12/08/2005WO2005116009A1 Substituted 2-quinolyl-oxazoles useful as pde4 inhibitors
12/08/2005WO2005116008A1 Process for producing piperidin-2,6-diones heterocyclically substituted at position 3
12/08/2005WO2005115993A1 Quinazoline derivative
12/08/2005WO2005115992A1 Theramutein modulators
12/08/2005WO2005115991A1 Anti-cytokine heterocyclic compounds
12/08/2005WO2005115990A1 Cinnamide compound
12/08/2005WO2005115986A1 Therapeutic compounds: pyridine as scaffold
12/08/2005WO2005115985A1 Aminopyridine derivatives as selective dopamine d3 agonists
12/08/2005WO2005115984A2 Large conductance calcium-activitated k channel opener
12/08/2005WO2005115983A1 Aryl sulfonamide and sulfonyl compounds as modulators of ppar and methods of treating metabolic disorders
12/08/2005WO2005115977A1 Pyrrolidine derivatives as cb1-receptor antagonists
12/08/2005WO2005115976A1 3-amino-2-phenylpyrrolidine derivatives
12/08/2005WO2005115975A1 Arylalkylamines and process for production thereof
12/08/2005WO2005115398A2 Hiv integrase inhibitors
12/08/2005WO2005115392A2 3-(4-heteroarylcyclohexylamino) cyclopentanecarboxamides as modulators of chemokine receptors
12/08/2005WO2005115145A2 Quinone substituted quinazoline and quinoline kinase inhibitors
12/08/2005WO2005087724A3 Sulphonylpyrroles as hdac inhibitors
12/08/2005WO2005077932A3 Chemokine receptor antagonists
12/08/2005WO2004098589A8 4- bromo - 5 - (2- chloro - benzoylamino) - 1h - pyrazole - 3 - carboxylic acid amide derivatives and related compounds as bradykinin b1 receptor antagonists for the treatment of inflammatory diseases
12/08/2005WO2004093798A3 Quinoxalinyl macrocyclic hepatitis c serine protease inhibitors
12/08/2005US20050272934 Process for the synthesis of thalidomide
12/08/2005US20050272931 Vanilloid receptor ligands and their use in treatments
12/08/2005US20050272803 Phosphodiesterase 4 inhibitors
12/08/2005US20050272793 Pyrazole compounds and uses related thereto
12/08/2005US20050272791 Lung melanoma metastasis, rheumatoid arthritis, 1-isopropylsulfonyl-2-amino-6-(2-(2,6-difluorophenyl)-5-(phenyl)-imidazol-4-yl)-benzimidazole
12/08/2005US20050272789 Triazole-derived kinase inhibitors and uses thereof
12/08/2005US20050272781 Protecting the hydroxyls of 3-hydroxy-4,5-dimethylol-2-picoline, reacting the 4-methylol group with an imide (especially potasssium phthalimide), cleaving the imide group to deprotect the amine group, and deprotecting the remaining hydroxy groups; post-Amadori advanced glycation end-products.
12/08/2005US20050272780 Small molecule inhibitors of rotamase enzyme activity
12/08/2005US20050272777 Vanilloid receptor ligands and their use in treatments
12/08/2005US20050272765 Dipeptidyl peptidase inhibitors
12/08/2005US20050272753 signal transducer and activator of transcription-6 inhibitors; asthma, COPD, respiratory, inflammatory and allergic diseases; compounds have less suppressive effect on immunological functions; 4-[(2,5 -difluorobenzyl) amino]-2-[(4-morpholin-4-ylphenyl)amino]pyrimidine-5 -carboxamide
12/08/2005US20050272752 Complexes of E-2-Methoxy-N-(3-{4-[3-methyl-4-(6-methyl-pyridin-3-yloxy)-phenylamino]-quinazolin-6-yl}-allyl)-acetamide and methods of preparing same
12/08/2005US20050272751 Inhibitors of Rho kinase; N-Benzyloxycarbonyl-4-[N''-(tert-butyloxycarbonyl)hydrazino]piperidine; 4-{[N''-(tert-butyloxycarbonyl)-N'-(1'-propyl)]hydrazino}piperidine
12/08/2005US20050272745 Novel piperidine and piperazine derivatives
12/08/2005US20050272736 Tri- and bi-cyclic heteroaryl histamine-3 receptor ligands
12/08/2005US20050272733 1-substituted pyridine-2-ones or 2-substituted pyridazin-3-ones; anticarcinogenic agents for breast and prostate cancer; contraceptives; endometriosis, benign prostatic hypertophy
12/08/2005US20050272728 Bicyclic-substituted amines having cyclic-substituted monocyclic substituents
12/08/2005US20050272715 Optically active dihydropyridine derivative
12/08/2005US20050272709 tert-butyl-[5-methyl-4-(phenylhydrazono)-4H-pyrazol-3-yl]amine; 4-(3-fluorophenylhydrazono)-5-methyl-2H-pyrazol-3-ylamine; demonstrate anti-proliferative activity, and may promote apoptosis in cells lacking normal regulation of cell cycle and death
12/08/2005US20050272663 Novel substituted prolines as inhibitors of hepatitis C virus NS3 serine protease
12/08/2005US20050272036 Ketones
12/08/2005US20050271736 Hydroxy-, amino-, and mercapto-substituted 1-oxydihydropyridine-2-thiones; and adducts with polyvalent isocyanates, which when polymerized form microcapsule walls; for use in industrial bactericides; chemical resistance
12/08/2005DE102004022897A1 Azinyl-imidazoazine Azinyl-imidazoazines
12/08/2005CA2569081A1 Quinazoline derivative
12/08/2005CA2568050A1 Indazole and indolone derivatives and their use as pharmaceuticals
12/08/2005CA2568046A1 3-amino-2-phenylpyrrolidine derivatives
12/08/2005CA2567813A1 Theramutein modulators
12/08/2005CA2566094A1 Cinnamide compound
12/08/2005CA2565486A1 3-(4-heteroarylcyclohexylamino)cyclopentanecarboxamides as modulators of chemokine receptors
12/08/2005CA2565065A1 Therapeutic compounds: pyridine as scaffold
12/08/2005CA2564884A1 Cyclohexylalanine derivatives as dipeptidyl peptidase-iv inhibitors for the treatment or prevention of diabetes
12/08/2005CA2564668A1 Pyrrolidine derivatives
12/08/2005CA2564638A1 Aryl sulfonamide and sulfonyl compounds as modulators of ppar and methods of treating metabolic disorders
12/08/2005CA2563466A1 Anti-cytokine heterocyclic compounds
12/07/2005EP1602654A1 Process for the synthesis of thalidomide
12/07/2005EP1602648A1 Nitrogen-containing heterocycle derivative and organic electroluminescent element using the same
12/07/2005EP1602647A1 Novel compound having 4-pyridylalkylthio group as substituent
12/07/2005EP1602645A1 Nitrogenous heterocyclic derivative having 2,6-disubstituted styryl
1 ... 535 536 537 538 539 540 541 542 543 544 545 546 547 548 549 550 551 552 553 554 555 ... 1080